How to Verify a Compounding Pharmacy Before You Trust It

A clear, clinician-written guide to checking licensure, testing, and sterility before you accept a compounded medication.

To verify a compounding pharmacy, confirm it holds an active state license, check whether it operates as a 503A or 503B facility, and request a certificate of analysis showing identity, potency, and sterility testing for the product you will receive. A trustworthy pharmacy answers these questions plainly and shares documentation without hesitation.

I get asked about this almost every week, usually by someone who has read something worrying online and wants to know if their medication is safe. It is a fair question, and a smart one. Compounded medications fill real gaps in care, but the quality behind them varies, and patients deserve to know how to tell the difference. So let me walk you through what I look at, in the same order I would explain it across the desk.

What is a licensed compounding pharmacy?

Compounding is the practice of preparing a medication for a specific need rather than pulling a finished, mass-produced product off a shelf. It is a long-standing part of pharmacy, older than the modern drug industry itself. What matters for you is the category the pharmacy operates under, because that shapes how it is regulated.

A 503A pharmacy prepares medications for an individual patient based on a prescription. Think of it as patient-specific work, overseen primarily by the state board of pharmacy. A 503B outsourcing facility is registered with the FDA and can produce larger batches under stricter manufacturing standards, often supplying clinics and providers. Neither label is automatically better for every situation. A 503B carries more federal oversight of its production process, while a quality 503A can do excellent, carefully documented work. The point is to know which one you are dealing with, and to confirm it is properly registered for that role.

What does a certificate of analysis actually show?

A certificate of analysis, often shortened to COA, is the lab document that backs up what is in the vial. A meaningful one will confirm the identity of the active ingredient, its potency or strength, and, for injectable products, results from sterility and endotoxin testing. It may also report on purity and the absence of certain impurities.

Here is the part people miss: a COA should be tied to the specific batch your medication came from, not a generic example posted on a website. When I evaluate a pharmacy, I want to see that testing is routine and traceable, performed by the facility or an independent lab. A pharmacy confident in its work will not treat this request as unusual. If you ask and the answer is vague, that tells you something on its own.

How do I check state licensure and inspection?

Every legitimate compounding pharmacy holds a license with the state board of pharmacy where it operates, and usually in the states it ships to as well. You can look this up. State boards maintain online verification tools where you can confirm a license is active and in good standing, and you can often see whether disciplinary actions are on record.

Inspection history matters too. Pharmacies are subject to inspection, and 503B facilities specifically fall under FDA inspection for their manufacturing practices. You will not always get a full inspection report as a patient, but you can ask whether the pharmacy has been inspected and whether any findings were resolved. A clinic that works with a pharmacy should be able to speak to this. At our practice, I expect to know exactly which pharmacies are filling prescriptions and what their standing is, because that is part of my responsibility, not the patient's homework.

Why is "not FDA-approved" not the same as unsafe?

This is where a lot of honest confusion lives, so I want to be careful and direct. Compounded semaglutide and compounded tirzepatide are not FDA-approved, and they are not identical to the brand versions. That is a true statement, and any provider who tells you otherwise is not being straight with you.

But "not FDA-approved" describes the product, not the pharmacy. FDA approval applies to specific, finished, mass-manufactured drugs that went through that agency's review. Compounded preparations, by their nature, are made to order and do not go through that same approval pathway. That does not mean they exist outside the rules. A compounding pharmacy is still licensed, still inspected, and still bound by standards for how it prepares and tests what it makes. Unregulated and not-FDA-approved are two different ideas, and conflating them either frightens people away from legitimate care or, worse, lulls them into thinking oversight does not exist at all.

For context on what the underlying molecules can do when properly prescribed and monitored: in the STEP-1 trial, semaglutide produced an average of about 14.9% of body weight lost, and in SURMOUNT-1, tirzepatide produced an average of about 20.9%. The SELECT trial showed cardiovascular benefit for semaglutide in adults with established cardiovascular disease and overweight or obesity. Those figures come from studies of the brand medications. Compounded versions are not identical, and results vary by individual. I share this so the conversation stays grounded, not to promise an outcome. (Ozempic and Wegovy are Novo Nordisk products; Mounjaro and Zepbound are Eli Lilly products; we are not affiliated with either company.)

What should I know about sterility and testing?

Anything you inject has to be sterile, full stop. Sterile compounding follows specific standards for the environment it is made in, the way it is handled, and how the finished product is tested. For an injectable like a GLP-1 medication, I want to know that the preparation was made under appropriate sterile conditions and that the batch was tested for sterility and for endotoxins, which are byproducts that can cause reactions even when no live organisms are present.

Stability and beyond-use dating matter as well. A responsible pharmacy assigns a date after which the product should not be used, based on testing rather than a guess. If a pharmacy cannot tell you how its sterile products are tested, that is a gap worth taking seriously.

What are the red flags?

A few patterns make me pause, and I think they should make you pause too:

• No clear license you can verify, or evasiveness when you ask which state board oversees them.
• Refusal or inability to provide a batch-specific certificate of analysis.
• Marketing that calls a compounded product "the same as" or a copy of a brand drug, or that promises guaranteed results.
• Selling prescription medication without a real clinical evaluation or any prescriber involvement.
• Prices or claims that seem designed to rush you past questions rather than answer them.
• No way to reach a pharmacist or licensed provider with a question about your medication.

None of these is a personal accusation against anyone. They are simply practices, and practices are what you can evaluate.

What should I ask my provider?

You do not need to become a pharmacist to protect yourself. A handful of direct questions will tell you most of what you need to know. Ask which pharmacy fills your prescription and whether it is a 503A or 503B facility. Ask to see a certificate of analysis for your product. Ask how sterility is ensured. Ask how the clinic vets the pharmacies it works with, and who you can call if something feels off after you start.

A good clinic welcomes these questions because the answers are already in order. In our practice, an initial consult is $119, and we are transparent about how care works, including compounded semaglutide at $166 per month and compounded tirzepatide at $233 per month, with structured 90-day options. The price is easy to quote. The standards behind the medication are what actually earn your trust, and you have every right to ask about them before you commit.

Verifying a pharmacy is not about suspicion. It is about being an informed partner in your own care. The questions above are the same ones I would want a member of my own family to ask, and the right answers are not hard for a quality pharmacy to give.

Frequently asked questions

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.